Welcome to IndianaLifeScience.com
IndianaLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Indiana
Are you considering a move to Indiana? Relocating your business to
Indiana? Starting a company? Or just interested in Indiana?
This section will answer many of your questions regarding the life science industry in Indiana, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Cardinal Health, SRI Surgical sign five-year agreement for surgical kits Cardinal Health and SRI/Surgical Express announced a five-year supply and co-marketing agreement to offer surgical kits that include disposable health care products from Cardinal Health and reusable health care products from SRI Surgical.
Cardinal Health December 01, 2008
- Johnson & Johnson announces definitive agreement to acquire Mentor Johnson & Johnson and Mentor Corporation, a leading supplier of medical products for the global aesthetic market, announced a definitive agreement whereby Mentor will be acquired for approximately $1.07 billion in a cash tender offer.
Johnson & Johnson December 01, 2008
- Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain Eli Lilly and Company has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain.
Eli Lilly and Company November 28, 2008
- MedImmune receives FDA Complete Response letter on motavizumab AstraZeneca announced that MedImmune, its wholly owned biologics business, has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) asking for additional information on motavizumab.
AstraZeneca November 28, 2008
- Stem cell research excites colleges Scientists at two of the state's three big research universities, the University of Michigan and Wayne State University, say that, with the passage of Proposal 2, they expect to expand their work on human embryonic stem cells in coming months.
The Lansing State Journal (Mich.) November 26, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Indiana's BioHistory
Why is there a biotechnology industry in Indiana? Will the industry continue
to grow in Indiana? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Indiana BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Indiana.
More...
BioEvolution Posters
More...
Celebrate Life: World AIDS Day 2008
December 1 is World AIDS Day; a time to celebrate the many lives saved by HIV prevention and treatment programs.
It also serves as a reminder that we all must do more - as individuals, communities, and as world citizens - to fight the spread
of HIV and AIDS.
Around the world, 33 million people are living with HIV with nearly 7,500 new infections occurring each day. An estimated 3
million people are now receiving antiretroviral treatment in low and middle-income countries.
More...
BioFact
(1975) - Monoclonal antibodies first produced by Georges Köhler and César Milstein.
It's a Small World
|
| |
Dust Pathogens
| |
Science Quote
"The things that will destroy us are: politics without principle; pleasure without conscience; wealth without work; knowledge without character; business without morality; science without humanity; and worship without sacrifice. "
| - |
Mahatma Gandhi, Spiritual/political leader
|
|
(1869-1948)
|
|
